VCG
Vantage Consulting Group’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,655
| Closed | -$235K | – | 26 |
|
|
2024
Q2 | $235K | Buy |
5,655
+1,236
| +28% | +$51.3K | 0.17% | 128 |
|
|
2024
Q1 | $240K | Sell |
4,419
-233
| -5% | -$12.6K | 0.15% | 140 |
|
|
2023
Q4 | $239K | Buy |
4,652
+844
| +22% | +$43.3K | 0.16% | 146 |
|
|
2023
Q3 | $221K | Buy |
3,808
+258
| +7% | +$15K | 0.15% | 158 |
|
|
2023
Q2 | $227K | Sell |
3,550
-98
| -3% | -$6.27K | 0.13% | 172 |
|
|
2023
Q1 | $253K | Buy |
3,648
+576
| +19% | +$39.9K | 0.14% | 148 |
|
|
2022
Q4 | $221K | Sell |
3,072
-590
| -16% | -$42.5K | 0.13% | 169 |
|
|
2022
Q3 | $260K | Buy |
3,662
+454
| +14% | +$32.2K | 0.15% | 100 |
|
|
2022
Q2 | $247K | Sell |
3,208
-127
| -4% | -$9.78K | 0.14% | 132 |
|
|
2022
Q1 | $244K | Sell |
3,335
-1,281
| -28% | -$93.7K | 0.1% | 156 |
|
|
2021
Q4 | $288K | Buy |
4,616
+764
| +20% | +$47.7K | 0.08% | 109 |
|
|
2021
Q3 | $228K | Buy |
3,852
+486
| +14% | +$28.8K | 0.05% | 165 |
|
|
2021
Q2 | $225K | Buy |
+3,366
| New | +$225K | 0.04% | 175 |
|
|
2021
Q1 | – | Sell |
-1,201
| Closed | -$74K | – | 304 |
|
|
2020
Q4 | $74K | Buy |
+1,201
| New | +$74K | 0.01% | 282 |
|